Canada’s Drug Agency | Drugs, Health Technologies and Systems.

Aripiprazole

Details

Files
Generic Name:
Aripiprazole
Project Status:
Received
Therapeutic Area:
Depression
Call for patient/clinician input open:
Brand Name:
N/A
Project Line:
Reimbursement Review
Project Number:
SX0756-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC
Biosimilar:
No
Submission Type:
Non-sponsored Submission
Fee Schedule:
Pending
Indications:
​Major Depressive Disorder (MDD)
Key Milestones2
Submission received12-Mar-25

Files

Proposed Scope View PDF
Last Updated : April 4, 2025